Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 2 institutions in 1 country.
Mikaeel YoungDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-1666-4111
Michaelle ChojnackiDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-0245-9918
Catlyn BlanchardDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Xufeng CaoDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, Lafayette, IN 47907, USA.
William L JohnsonDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-2616-2553
Daniel FlahertyDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, Lafayette, IN 47907, USA.ORCID 0000-0002-8305-0606
Paul M DunmanDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
University of Rochester Medical Center · USPurdue University West Lafayette · US
Funding
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Inhibitors of adaptive efflux mediated resistance in Acinetobacter baumanniiR01AI175024 · NIAID · UNIVERSITY OF ROCHESTER · PI Paul M. Dunman, Daniel Patrick Flaherty · 2023 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic Determinants of · full record | OpenQuestion